- Report
- November 2024
- 290 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 285 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 134 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 270 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 184 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 184 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 286 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 289 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 296 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 183 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 276 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 193 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 390 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 381 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 287 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 121 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 474 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 369 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 384 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 274 Pages
Global
From €5531EUR$5,600USD£4,602GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more